rs13335638

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000548.5(TSC2):​c.4850-109T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.186 in 1,538,084 control chromosomes in the GnomAD database, including 33,023 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 8001 hom., cov: 33)
Exomes 𝑓: 0.18 ( 25022 hom. )

Consequence

TSC2
NM_000548.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: -3.40

Publications

13 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 16-2086623-T-C is Benign according to our data. Variant chr16-2086623-T-C is described in ClinVar as Benign. ClinVar VariationId is 65253.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.535 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSC2NM_000548.5 linkc.4850-109T>C intron_variant Intron 37 of 41 ENST00000219476.9 NP_000539.2 P49815-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSC2ENST00000219476.9 linkc.4850-109T>C intron_variant Intron 37 of 41 5 NM_000548.5 ENSP00000219476.3 P49815-1

Frequencies

GnomAD3 genomes
AF:
0.275
AC:
41725
AN:
151976
Hom.:
7964
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.540
Gnomad AMI
AF:
0.0978
Gnomad AMR
AF:
0.198
Gnomad ASJ
AF:
0.240
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0928
Gnomad FIN
AF:
0.232
Gnomad MID
AF:
0.259
Gnomad NFE
AF:
0.175
Gnomad OTH
AF:
0.249
GnomAD4 exome
AF:
0.177
AC:
244845
AN:
1385990
Hom.:
25022
AF XY:
0.173
AC XY:
118993
AN XY:
686782
show subpopulations
African (AFR)
AF:
0.550
AC:
17408
AN:
31676
American (AMR)
AF:
0.130
AC:
5094
AN:
39232
Ashkenazi Jewish (ASJ)
AF:
0.242
AC:
5935
AN:
24502
East Asian (EAS)
AF:
0.000241
AC:
9
AN:
37386
South Asian (SAS)
AF:
0.0962
AC:
7763
AN:
80720
European-Finnish (FIN)
AF:
0.223
AC:
8067
AN:
36172
Middle Eastern (MID)
AF:
0.234
AC:
934
AN:
3998
European-Non Finnish (NFE)
AF:
0.176
AC:
188646
AN:
1074668
Other (OTH)
AF:
0.191
AC:
10989
AN:
57636
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
10836
21672
32507
43343
54179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6746
13492
20238
26984
33730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.275
AC:
41810
AN:
152094
Hom.:
8001
Cov.:
33
AF XY:
0.272
AC XY:
20214
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.541
AC:
22429
AN:
41470
American (AMR)
AF:
0.198
AC:
3024
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.240
AC:
833
AN:
3472
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5170
South Asian (SAS)
AF:
0.0925
AC:
446
AN:
4822
European-Finnish (FIN)
AF:
0.232
AC:
2457
AN:
10586
Middle Eastern (MID)
AF:
0.265
AC:
78
AN:
294
European-Non Finnish (NFE)
AF:
0.175
AC:
11928
AN:
67970
Other (OTH)
AF:
0.247
AC:
520
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1406
2812
4219
5625
7031
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
376
752
1128
1504
1880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.157
Hom.:
478
Bravo
AF:
0.284
Asia WGS
AF:
0.0830
AC:
291
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 31, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 23% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 21. Only high quality variants are reported. -

not provided Benign:1
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Tuberous sclerosis syndrome Other:1
-
Tuberous sclerosis database (TSC2)
Significance:not provided
Review Status:no classification provided
Collection Method:curation

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.82
DANN
Benign
0.43
PhyloP100
-3.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13335638; hg19: chr16-2136624; API